Together, these pre-clinical results identify parafacial Phox2b+ neurons as a contributing factor to disordered breathing in PTHS, and establish Nav1.8 channels as a high priority target with therapeutic potential in this disease. This evidence concerns the gene SCN10A and Pitt-Hopkins syndrome.